DEXRAZOXANE

作品数:4被引量:13H指数:1
导出分析报告
相关领域:医药卫生更多>>
相关期刊:《国外新药介绍》《South China Journal of Cardiology》《World Journal of Clinical Oncology》《Nano Research》更多>>
相关基金:国家自然科学基金上海市自然科学基金广东省自然科学基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-4
视图:
排序:
Renal tubule-targeted dexrazoxane suppresses ferroptosis in acute kidney injury by inhibiting ACMSD
《Nano Research》2023年第7期9701-9714,共14页Yunjing Zhang Jicheng Wu Quanlin An Huanhuan Zhu Xinwan Su Ying Wang Xishao Xie Jian Zhang Xi Yao Chunhua Weng Shi Feng Jianhua Mao Xianghui Fu Fei Han Xin Cao Ben Wang Weiqiang Lin 
This work was supported by grants from Zhejiang Provincial Natural Science Foundation of China(No.LZ22H050001);the National Natural Science Foundation of China(Nos.81970573,81670651,81900683,82000637,and 82173662);Zhejiang provincial program for the Cultivation of High-level Innovative Health talents,Natural Science Foundation of Shanghai(No.20ZR1410400);Medical Health Science and Technology Project of Zhejiang Provincial Health Commission(No.2020KY538).
Acute kidney injury(AKI)is a heterogeneous clinical complication with no existing definite or particular therapies.Therefore,molecular mechanisms and approaches for treating acute kidney injury are in urgent need.Here...
关键词:DEXRAZOXANE dexrazoxane-polysialic acid acute kidney injury ischemia-reperfusion injury ferroptosis α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase(ACMSD) 
Overview, prevention and management of chemotherapy extravasation被引量:12
《World Journal of Clinical Oncology》2016年第1期87-97,共11页Firas Y Kreidieh Hiba A Moukadem Nagi S El Saghir 
Chemotherapy extravasation remains an accidental complication of chemotherapy administration and may result in serious damage to patients. We review in this article the clinical aspects of chemotherapy extravasation a...
关键词:CHEMOTHERAPY EXTRAVASATION Vesicant Tissue damage Dimethyl SULFOXIDE DEXRAZOXANE ANTIDOTE HYALURONIDASE 
MicroRNAs participate in the cardioprotective activity of dexrazoxane against doxorubicin-induced cardiotoxicity被引量:1
《South China Journal of Cardiology》2012年第3期169-179,196,共12页符永恒 朱杰宁 黄帅 郭林林 林秋雄 张梦珍 谭虹虹 邝素娟 杨惠 费洪文 李文瑜 单志新 
supported by Grants from the National Natural Science Foundation of China (No. 81070102);Foundation of the Guangdong Provincial Science and Technology (20100309);the Natural Science Foundation of the Guangdong Province (Nos. 10151008004000035, S2011020005911)
Background The co-administration of dexrazoxane (DEX) with each dose of doxoruhicin (Dox) is an efficient strategy to relieve Dox-induced cardiotoxicity, however, the mechanisms underlying the cardioprotective eff...
关键词:CARDIOTOXICITY DOXORUBICIN DEXRAZOXANE APOPTOSIS cardiac remodeling MICRORNAS 
心脏保护剂——Dexrazoxane
《国外新药介绍》1999年第3期5-7,共3页关旭俊 
关键词:心脏保护剂 DEXRAZOXANE 耐受性 临床疗效 
检索报告 对象比较 聚类工具 使用帮助 返回顶部